US Patent Issued to Regeneron Pharmaceuticals on May 12 for "Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies" (New York, New Jersey Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,115, issued on May 12, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies" was invented by Daniel B. Dix (LaGrangeville, N.Y.) and Xiaolin Tang (Old Tappan, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides pharmaceutical formulations comprising a human antibody that specifically binds to human interleukin-4 receptor (hIL-4R). The formulations may contain, in addition to an anti-hIL-4R antibody, at least one amino acid, at least one sugar, or at least one non-ionic surfactant. The pharmaceutical formulations of the presen...